Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-19-059085
Filing Date
2019-12-04
Accepted
2019-12-04 16:42:13
Documents
1
Period of Report
2019-12-02

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 7486
  Complete submission text file 0001209191-19-059085.txt   8923
Mailing Address C/O ADURO BIOTECH, INC. 740 HEINZ AVENUE BERKELEY CA 94710
Business Address
Sacks Natalie (Reporting) CIK: 0001683811 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38800 | Film No.: 191268587

Mailing Address 131 OYSTER POINT BOULEVARD SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 131 OYSTER POINT BOULEVARD SUITE 300 SOUTH SAN FRANCISCO CA 94080 650-443-7400
Harpoon Therapeutics, Inc. (Issuer) CIK: 0001708493 (see all company filings)

EIN.: 473458693 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)